Tencent led the medical imaging startup’s series A+ round, which increased its overall funding to almost $29m.
Month: October 2017
SB Isat shares funding data
The Indonesia-based fund, formed by telecom companies SoftBank and Indosat in 2014, has invested 80% of its $50m but has no plans to raise more capital.
ShareChat calls on Xiaomi for $15m round
Smartphone maker Xiaomi and venture firm Shunwei Capital have signed a term sheet to co-lead a series B round that will value the social media app developer at up to $70m.
Drive.ai gets a Grab in $15m round
Grab joined undisclosed others to invest $15m in Drive.ai, a developer of AI software for driverless cars, bringing its total funding up to $77m.
Kinova clasps $20m
Foxconn has contributed to a $20m round for robotic arm technology developer Kinova that was led by BDC Capital.
Roku rocks IPO up to $253m
The underwriters for the corporate-backed television subscription platform’s IPO have fully exercised the over-allotment option.
Ola gets nearer to $2bn series G close
SoftBank is reportedly set to add funding to a round that will include a $400m investment by Tencent that has already been agreed.
Cloud9 trains for $25m investment
The esports company, backed by FunPlus and United Talent Agency, has secured $19.7m out of a targeted $25m in funding.
Union Square Hospitality serves up $200m fund
The restaurant group has closed an oversubscribed fund that included commitments from external investors and will focus on companies in the hospitality sector.
Corporates inject series A capital in Thermalin
Insulin developer Thermalin has raised an undisclosed sum from investors including Sanofi and JSR, and plans to close the round at $17.5m.
Dialpad’s series C talks lift round to $52m
The enterprise communication platform has raised $17m from investors including GV, a participant in the round’s 2015 first tranche, which also featured SoftBank.
Magenta Medical colours in $15m series B
Magenta, the developer of a heart failure treatment device, has added an Abiomed-backed series B round to the $4m series A it raised five years ago.
Cardinal Analytx assesses series A funding
Health insurer Premera Blue Cross has backed a $6.1m series A round for Cardinal Analytx, developer of technology that calculates the potential risk of new policy buyers.
Evotec executes Exscientia deal
Evotec has invested $17.7m in Exscientia, becoming the first strategic shareholder in the drug discovery spinout, which is based on research at University of Dundee.